
This winter, there’s another new SARS-CoV-2 variant contributing to surges around the world. The World Health Organization (WHO) classified this variant, called JN.1, as a “variant of interest” on December 19, signifying that it is worth the attention of scientists and healthcare workers. In the U.S., JN.1 may lead to higher levels of coronavirus spread…

Research and advocacy updates for the week of January 2 include new research about a drug candidate for Long Covid and ME, markers of brain injury, Paxlovid, and a Twitter campaign.

This winter’s Covid-19 surge continues in the U.S. While data aren’t yet available for the weeks after Christmas and New Years, wastewater surveillance suggests there could be more SARS-CoV-2 going around right now than reported at this time last year — with variant JN.1 fueling the spread from holiday travel and gatherings.

Last week, clinical epidemiologist Ziyad Al-Aly and his team at Washington University and the St. Louis Veterans Affairs (VA) health system published a new paper demonstrating that Covid-19 has a higher long-term health burden than the flu. Betsy Ladyzhets from The Sick Times talked to Al-Aly about his new paper and other areas of Long…

Covid-19 spread continues to increase across the country — along with the spread of other respiratory viruses — as the U.S. heads into our busiest period of travel and holiday gatherings. Despite this winter following the same disease trends as we saw the last three years, public health institutions have failed to prepare any better;…

This fall, the federal government announced a new grant program to support Long Covid care: the Agency for Healthcare Research and Quality (AHRQ) awarded million-dollar grants to nine Long Covid clinics across the country, designed to help these centers extend their reach and develop best practices for addressing this complex chronic disease. Each clinic can…

Both Covid-19 and respiratory virus season metrics point to ongoing increases in disease spread across the country, though some regions (particularly the Midwest) are seeing more SARS-CoV-2 infections than others right now. The federal government continues to take insufficient responses to Covid-19 and other common diseases.

Project N95, the nonprofit organization that distributes high-quality masks and other Covid-19 safety equipment, announced last month that it will wind down its operations at the end of 2023. This closure marks the end of an effort that provided a trustworthy place to buy masks online and distributed millions of free masks to communities in…

As I anticipated last week, major metrics for Covid-19 and other respiratory viruses show increased disease spread during the week of Thanksgiving. This trend will likely continue through December (if not longer) as Americans continue to travel and gather for the holidays with relatively few precautions.

Today, on Giving Tuesday, an internationally recognized day for giving to charity, please consider donating to our nonprofit newsroom at The Sick Times. We aim to raise $75,000 as we build a full news website in 2024.
advocacy arts CDC clinical trials commentary COVID-19 precautions disability essay government policy H5N1 healthcare HHS influenza international Long COVID in children masks and respirators ME ME/CFS medical education national COVID-19 trends NIH NIH RECOVER podcast public health research update science Trump administration updates and events vaccines wastewater surveillance